Uncategorized

GSK plans five Phase 3 studies for gynecological cancer ADC from Hansoh

GSK plans five Phase 3 studies for gynecological cancer ADC from Hansoh

Published

5 hours ago

on

GSK shared early promising data Sunday from the antibody-drug conjugate it licensed from its Chinese partner Hansoh Pharma. The UK company now plans to start studying the asset in five Phase 3 studies in gynecological …​ ​Read More

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version